Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22397228 | 0.91 | RIPK1 (0.52) | RIPK1 | |
| SCHEMBL22371304 | 0.87 | RIPK1 (0.64) | RIPK1PIK3CA | |
| SCHEMBL22397188 | 0.84 | RIPK1 (0.54) | RIPK1 | |
| SCHEMBL22397196 | 0.83 | RIPK1 (0.53) | RIPK1 | |
| SCHEMBL30468327 | 0.82 | PIK3CA (0.66) | RIPK1PIK3CA | |
| SCHEMBL22370937 | 0.82 | PIK3CA (0.66) | RIPK1PIK3CA | |
| SCHEMBL22371316 | 0.76 | RIPK1 (0.67) | RIPK1 | |
| SCHEMBL22371382 | 0.75 | RIPK1 (0.55) | RIPK1PIK3CA | |
| SCHEMBL30468375 | 0.75 | RIPK1 (0.55) | RIPK1PIK3CA | |
| Lithium Ion SCHEMBL29849297 | 0.73 | RIPK1 (0.65) | RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3704118-A1 | AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2020-09-09 | — | — | EP | disclosed |